86 related articles for article (PubMed ID: 1918168)
1. Differential expression of two classes of lck transcripts upon phorbol ester treatment of human leukemic T cells.
Leung S; Miyamoto NG
J Cell Physiol; 1991 Sep; 148(3):344-52. PubMed ID: 1918168
[TBL] [Abstract][Full Text] [Related]
2. Expression of the human T-cell-specific tyrosine kinase YT16 (lck) message in leukemic T-cell lines.
Koga Y; Kimura N; Minowada J; Mak TW
Cancer Res; 1988 Feb; 48(4):856-9. PubMed ID: 3257410
[TBL] [Abstract][Full Text] [Related]
3. Phorbol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell leukemia line JURKAT.
Makover D; Cuddy M; Yum S; Bradley K; Alpers J; Sukhatme V; Reed JC
Oncogene; 1991 Mar; 6(3):455-60. PubMed ID: 2011401
[TBL] [Abstract][Full Text] [Related]
4. Pattern of expression of five alternative transcripts of the lck gene in different hematopoietic malignancies: correlation of the level of lck messenger RNA I B with the immature phenotype of the malignancy.
Rouer E; Dreyfus F; Melle J; Benarous R
Cell Growth Differ; 1994 Jun; 5(6):659-66. PubMed ID: 8086341
[TBL] [Abstract][Full Text] [Related]
5. Requirement of an ETS-binding element for transcription of the human lck type I promoter.
Leung S; McCracken S; Ghysdael J; Miyamoto NG
Oncogene; 1993 Apr; 8(4):989-97. PubMed ID: 8455950
[TBL] [Abstract][Full Text] [Related]
6. Myb and Ets related transcription factors are required for activity of the human lck type I promoter.
McCracken S; Leung S; Bosselut R; Ghysdael J; Miyamoto NG
Oncogene; 1994 Dec; 9(12):3609-15. PubMed ID: 7970721
[TBL] [Abstract][Full Text] [Related]
7. An alternative pathway for expression of p56lck from type I promoter transcripts in colon carcinoma.
McCracken S; Kim CS; Xu Y; Minden M; Miyamoto NG
Oncogene; 1997 Dec; 15(24):2929-37. PubMed ID: 9416836
[TBL] [Abstract][Full Text] [Related]
8. Expression of alternatively spliced lck transcripts from the proximal promoter in colorectal cancer derived cell lines.
Mayer K; Ballhausen WG
Anticancer Res; 1996; 16(4A):1733-7. PubMed ID: 8712692
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of two lck transcripts directed from the distinct promoters in HTLV-I+ and HTLV-I- T-cells.
Nakamura K; Koga Y; Yoshida H; Kimura G; Nomoto K
Int J Cancer; 1991 Jul; 48(5):789-93. PubMed ID: 1712760
[TBL] [Abstract][Full Text] [Related]
10. Absence of transcription of lck (lymphocyte specific protein tyrosine kinase) message in IL-2-independent, HTLV-I-transformed T cell lines.
Koga Y; Oh-Hori N; Sato H; Yamamoto N; Kimura G; Nomoto K
J Immunol; 1989 Jun; 142(12):4493-9. PubMed ID: 2786034
[TBL] [Abstract][Full Text] [Related]
11. Alternative splicing in the human lck gene leads to the deletion of exon 1' and results in a new type II lck transcript.
Rouer E; Benarous R
Oncogene; 1992 Dec; 7(12):2535-8. PubMed ID: 1461657
[TBL] [Abstract][Full Text] [Related]
12. Phorbol ester 12-O-tetradecanoylphorbol-13-acetate down-regulates expression of the c-kit proto-oncogene product.
Asano Y; Brach MA; Ahlers A; de Vos S; Butterfield JH; Ashman LK; Valent P; Gruss HJ; Herrmann F
J Immunol; 1993 Sep; 151(5):2345-54. PubMed ID: 7689605
[TBL] [Abstract][Full Text] [Related]
13. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
14. The catalytic domain of pp56(lck), but not its regulatory domain, is sufficient for inducing IL-2 production.
Carrera AC; Calvo V; Borlado LR; Paradis H; Alemany S; Roberts TM; Martinez-A C
J Immunol; 1996 Nov; 157(9):3775-82. PubMed ID: 8892605
[TBL] [Abstract][Full Text] [Related]
15. Functional dissection of the murine lck distal promoter.
Wildin RS; Wang HU; Forbush KA; Perlmutter RM
J Immunol; 1995 Aug; 155(3):1286-95. PubMed ID: 7636195
[TBL] [Abstract][Full Text] [Related]
16. Structure of the two promoters of the human lck gene: differential accumulation of two classes of lck transcripts in T cells.
Takadera T; Leung S; Gernone A; Koga Y; Takihara Y; Miyamoto NG; Mak TW
Mol Cell Biol; 1989 May; 9(5):2173-80. PubMed ID: 2787474
[TBL] [Abstract][Full Text] [Related]
17. Lck tyrosine kinase is important for activation of the CD11a/CD18-integrins in human T lymphocytes.
Fagerholm S; Hilden TJ; Gahmberg CG
Eur J Immunol; 2002 Jun; 32(6):1670-8. PubMed ID: 12115650
[TBL] [Abstract][Full Text] [Related]
18. Induction of integrated adenovirus E1A and E1B genes in transformed human cells by phorbol ester tumor promoters.
Carter T; James C; Chan E; Greene B
Cancer Res; 1987 Feb; 47(3):803-8. PubMed ID: 2948635
[TBL] [Abstract][Full Text] [Related]
19. A single base mutation in the 5' splice site of intron 7 of the lck gene is responsible for the deletion of exon 7 in lck mRNA of the JCaM1 cell line.
Rouer E; Brule F; Benarous R
Oncogene; 1999 Jul; 18(29):4262-8. PubMed ID: 10435639
[TBL] [Abstract][Full Text] [Related]
20. Structure and expression of lck transcripts in human lymphoid cells.
Perlmutter RM; Marth JD; Lewis DB; Peet R; Ziegler SF; Wilson CB
J Cell Biochem; 1988 Oct; 38(2):117-26. PubMed ID: 3265417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
